BiotechTube
Home/Evozyne/Uri Herzberg, PhD, DVM, MBA
UH

Uri Herzberg, PhD, DVM, MBA

Chief Drug Discovery Officer

Evozyne

Therapeutic Areas

Immune-mediated diseases

Evozyne Pipeline

DrugIndicationPhase
IgG ProteasesImmune-mediated diseases (Autoimmune)Pre-clinical
Next-generation CytokinesImmuno-oncology / Inflammatory diseasesPre-clinical
Respiratory Disease CandidatesRespiratory inflammatory diseasesPre-clinical

Leadership Team at Evozyne

MY
Marc Yoskowitz
Chief Executive Officer
AR
Arjun Rallapalli, PhD
Chief Operating Officer
SW
Stephen Wanaski, PhD
SVP, Research & Exploratory Development
View full Evozyne profile